News

Daval International has received Orphan-Drug designation for its anti-inflammatory agent Aimspro for the treatment of amyotrophic lateral sclerosis (ALS) from the FDA. The company said that Aimspro has

As per the agreement, Vertex will utilise Bend’s formulation development and manufacturing services for specific projects and clinical trials, with the goals of both enhancing the delivery of

TNO and Seventh Wave Laboratories (Seventh Wave) have signed a letter of intent with regard to TNO’s in-vitro gastrointestinal models TIM. The letter of intent proposes a collaboration

Enzon Pharmaceuticals has entered into a definitive agreement to sell its specialty pharmaceutical business to the Sigma-Tau Group for $300m plus an additional amount of up to $27m

D-Pharm has entered into a licensing, co-development and supply agreement with Wanbang Biopharmaceuticals, for commercialisation of DP-b99 in the People’s Republic of China. DP-b99 is a novel drug

Harro Hofliger has introduced OmniControl, which is a modular checking system for maximum flexibility with the weighing of solida. The company said that OmniControl is the format-free checking

Conceptus has reported that the US District Court, Northern District of California has denied Conceptus’ motion for a preliminary injunction prohibiting Hologic, from importing, using, selling or offering

The FDA has approved Istodax (romidepsin), an injectable medication, for treatment of patients with cutaneous T-cell lymphoma (CTCL). Istodax interferes with processes required for cell replication. It is

The acquisition of the manufacturing license will be effected through the acquisition of equity in Tianda as well as transfer of certain technologies from Tianda. Rosuvastatin was first